S
Susan C. Wu
Researcher at University of North Carolina at Chapel Hill
Publications - 9
Citations - 4432
Susan C. Wu is an academic researcher from University of North Carolina at Chapel Hill. The author has contributed to research in topics: DNA methylation & EZH2. The author has an hindex of 8, co-authored 9 publications receiving 4028 citations. Previous affiliations of Susan C. Wu include Buck Institute for Research on Aging.
Papers
More filters
Journal ArticleDOI
Tet proteins can convert 5-methylcytosine to 5-formylcytosine and 5-carboxylcytosine
Shinsuke Ito,Li Shen,Qing Dai,Susan C. Wu,Leonard B. Collins,James A. Swenberg,Chuan He,Yi Zhang +7 more
TL;DR: This study raises the possibility that DNA demethylation may occur through Tet-catalyzed oxidation followed by decarboxylation, and identifies two previously unknown cytosine derivatives in genomic DNA as the products of Tet proteins.
Journal ArticleDOI
Active DNA demethylation: many roads lead to Rome
Susan C. Wu,Yi Zhang +1 more
TL;DR: Insight into how DNA methylation is dynamically regulated will broaden the understanding of epigenetic regulation and have great implications in somatic cell reprogramming and regenerative medicine.
Journal ArticleDOI
Cyclin-dependent Kinase 1 (CDK1)-mediated Phosphorylation of Enhancer of Zeste 2 (Ezh2) Regulates Its Stability
Susan C. Wu,Yi Zhang +1 more
TL;DR: It is demonstrated that Ezh2 can be regulated by the cyclin-dependent kinase, CDK1, which phosphorylates Ezh 2 at threonines 345 and 487, which is consistent with the cell cycle phase during whichCDK1 exhibits peak activity, and phosphorylation is enriched in cells arrested in mitosis when compared with S-phase.
Journal ArticleDOI
Role of H3K27 methylation in the regulation of lncRNA expression.
TL;DR: The results establish a role for Ezh2-mediated H3K27 methylation in lncRNA silencing in ES cells and reveal that lncRNAs are subject to epigenetic regulation in a similar manner to that of the protein-coding genes.
Journal ArticleDOI
Atypical recognition consensus of CIN85/SETA/Ruk SH3 domains revealed by target-assisted iterative screening.
TL;DR: Target-assisted iterative screening applied to random peptide libraries unveiled a novel and atypical recognition consensus shared by CIN85/SETA/Ruk SH3 domains, PX(P/A)XXR, which allowed for the accurate mapping of Cin85 SH3 binding sites within known CIN 85 interactors, c-Cbl, BLNK, Cbl-b, AIP1/Alix, SB1, and CD2 proteins, as well as